Movement Alert｜GENSCRIPT B-1K rises 6.84% in Regular Trading, FMR LLC stake increase boosts sentiment

Market Focus10-16

On October 16, GENSCRIPT B-1K rose 6.84% intraday, trading at HK$34.18, with turnover of HK$87.99 million.

The clearest catalyst was a fresh disclosed increase in holdings by FMR LLC, which supported market sentiment toward the stock.

Background details show FMR LLC increased its position on October 12 by 10.37 million shares at an average price of HK$42.0590 per share, involving about HK$436 million. This followed earlier increases on September 24 and October 2, after which its stake had risen to 6.01%. Recent disclosure that Legend Biotech core product CARVYKTI generated about US$710 million in trade net sales for the quarter ended September 30 also reinforced investor focus on the company’s longer-term growth in cell therapy and life sciences services.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment